Skip to content
value.today

Genoway: peers

Change the peers

Genoway beside the 7 companies most like it by industry, size and country: every figure with its date and source, its rank in the group and its percentile in its sector and country.

Genoway, GenSight Biologics S.A., Abionyx Pharma SA, Poxel S.A., Genkyotex SA, Fermentalg Societe Anonyme, Onxeo SA, OSE Immunotherapeutics SA: the market cap on file is more than 60 days old or a last known value (no market-data feed for their exchanges yet), so their valuation multiples and yields are shown but not ranked.

Side by side#

Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.

Genoway, GenSight Biologics S.A., Abionyx Pharma SA, Poxel S.A., Genkyotex SA, Fermentalg Societe Anonyme, Onxeo SA, OSE Immunotherapeutics SA side by side: each figure with its period and source, its rank among these companies and its percentile in the company's sector and country
MeasureGenowaybase
JEH.F · 🇫🇷 FR
Percentile in Healthcare
Percentile in France
GenSight Biologics S.A.
SIGHT.PA · 🇫🇷 FR
Percentile in Healthcare
Percentile in France
Abionyx Pharma SA
ABNX.PA · 🇫🇷 FR
Percentile in Healthcare
Percentile in France
Poxel S.A.
POXEL.PA · 🇫🇷 FR
Percentile in Healthcare
Percentile in France
Genkyotex SA
G061.F · 🇫🇷 FR
Percentile in Healthcare
Percentile in France
Fermentalg Societe Anonyme
1F6.F · 🇫🇷 FR
Percentile in Healthcare
Percentile in France
Onxeo SA
ONXEO.CO · 🇫🇷 FR
Percentile in Healthcare
Percentile in France
OSE Immunotherapeutics SA
OSE.PA · 🇫🇷 FR
Percentile in Healthcare
Percentile in France
Group median
Size
Market cap (Better neither way: ranked highest first)$36 Mlast known, Jul 30, 2023 · Market dataLast known value: no current one5th of 8$34 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one6th of 8$45 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one3rd of 8$22 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one8th of 8$41 Mlast known, Jan 1, 2021 · Market dataLast known value: no current one4th of 8$30 Mlast known, Jul 30, 2023 · Market dataLast known value: no current one7th of 8$46 Mlast known, Jan 7, 2022 · Market dataLast known value: no current one2nd of 8$101 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one1st of 8$39 M8 ranked
Revenue (Better neither way: ranked highest first)——$2 MFY2024 · ESEF4th of 4$5 MFY2025 · ESEF2nd of 4$7 MFY2024 · ESEF1st of 4——————$3 MFY2025 · ESEF3rd of 4$4 M4 ranked
Net income (Higher is better)——$-15 MFY2024 · ESEF2nd of 4$-6 MFY2025 · ESEF1st of 4$-20 MFY2024 · ESEF3rd of 4——————$-42 MFY2025 · ESEF4th of 4$-17 M4 ranked
Growth
Revenue growth (Higher is better)————+18.3%FY2024 · ESEF2nd of 365th93rd-7.1%FY2025 · ESEF3rd of 315th11th+235.5%FY2024 · ESEF1st of 397th98th————————————————+18.3%3 ranked
Margins and returns
Gross margin (Higher is better)————————————55.7%FY2024 · ESEFonly one with it45th52nd————————————————55.7%—
Operating margin (Higher is better)————————-136.2%FY2025 · ESEF2nd of 220th4th-52.8%FY2024 · ESEF1st of 231st8th————————————————-94.5%2 ranked
Net margin (Higher is better)————-935.2%FY2024 · ESEF3rd of 30th0th-136.7%FY2025 · ESEF1st of 319th4th-275.9%FY2024 · ESEF2nd of 312th2nd————————————————-275.9%3 ranked
Free cash flow margin (Higher is better)————-864.2%FY2024 · ESEF2nd of 21st1st-78.2%FY2025 · ESEF1st of 224th12th————————————————————-471.2%2 ranked
Return on equity (Higher is better)————————-95.5%FY2025 · ESEF2nd of 226th3rd————————————————-85.9%FY2025 · ESEF1st of 229th4th-90.7%2 ranked
Scorecard
Scorecard (Higher is better)——1 of 3FY2024 · Scorecard2nd of 40 of 6FY2025 · Scorecard3rd of 42 of 4FY2024 · Scorecard1st of 4——————0 of 3FY2025 · Scorecard3rd of 417% passed4 ranked
Growth checks (Higher is better)——1 of 2FY2024 · Scorecard1st of 40 of 2FY2025 · Scorecard3rd of 41 of 2FY2024 · Scorecard1st of 4——————0 of 1FY2025 · Scorecard3rd of 425% passed4 ranked
Profitability checks (Higher is better)——0 of 1FY2024 · Scorecard2nd of 40 of 4FY2025 · Scorecard2nd of 41 of 2FY2024 · Scorecard1st of 4——————0 of 2FY2025 · Scorecard2nd of 40% passed4 ranked

Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).

Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = Genoway: How market caps are worked out; GenSight Biologics S.A.: How market caps are worked out; Abionyx Pharma SA: How market caps are worked out; Poxel S.A.: How market caps are worked out; Genkyotex SA: How market caps are worked out; Fermentalg Societe Anonyme: How market caps are worked out; Onxeo SA: How market caps are worked out; OSE Immunotherapeutics SA: How market caps are worked out.

Where each stands in its sector and country: Operating margin#

The dot is the company; the line runs from the 10th to the 90th percentile of all the companies of its sector (or country) with the figure, the box holds the middle half and the tick is the median. Each company's newest fiscal year; figures that divide by the market value only with a market cap at most 60 days old. How percentiles are worked out.

Operating margin: each company's figure and its percentile in its sector and its country
CompanyOperating marginIn its sectorIn its country
Genoway———
GenSight Biologics S.A.———
Abionyx Pharma SA-136.2%FY2025
20th percentile in Healthcaremedian -7.7%, 674 companies
4th percentile in Francemedian 5.5%, 124 companies
Poxel S.A.-52.8%FY2024
31st percentile in Healthcaremedian -7.7%, 674 companies
8th percentile in Francemedian 5.5%, 124 companies
Genkyotex SA———
Fermentalg Societe Anonyme———
Onxeo SA———
OSE Immunotherapeutics SA———

Revenue by fiscal year, and the rank in the group#

Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).

Revenue

$0 M$19 M$38 M$57 M$76 M202320242025GenSight Biologics S.A. $2 MAbionyx Pharma SA $5 MPoxel S.A. $7 MOSE Immunotherapeutics SA $3 M

Rank in the group

1st2nd3rd4th202320242025GenSight Biologics S.A.: 2nd of 2 in 2023GenSight Biologics S.A.: 4th of 4 in 2024GenSight Biologics S.A.Abionyx Pharma SA: 3rd of 4 in 2024Abionyx Pharma SA: 1st of 2 in 2025Abionyx Pharma SAPoxel S.A.: 1st of 2 in 2023Poxel S.A.: 2nd of 4 in 2024Poxel S.A.OSE Immunotherapeutics SA: 1st of 4 in 2024OSE Immunotherapeutics SA: 2nd of 2 in 2025OSE Immunotherapeutics SA
Revenue by fiscal year with each company's rank in the group and the source of each figure
Fiscal yearGenowayGenSight Biologics S.A.Abionyx Pharma SAPoxel S.A.Genkyotex SAFermentalg Societe AnonymeOnxeo SAOSE Immunotherapeutics SA
2025——$5 MESEF1st————$3 MESEF2nd
2024—$2 MESEF4th$5 MESEF3rd$7 MESEF2nd———$76 MESEF1st
2023—$1 MESEF2nd—$2 MESEF1st————
2022——$6 MESEF—————

Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Ed. = The company's annual report, entered by value.today editors; WD = Wikidata, citing the annual report; Cap = value.today market caps (the last of each calendar year). The small ordinal is the rank in the group that year. Hover a figure for its fiscal year end.

Suggested peers of Genoway#

Companies of the same industry, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.

  • GenSight Biologics S.A.SIGHT.PA · 🇫🇷 France
    Same industry: Biotechnology · Similar size: $34 M market cap against $36 M · Same country: France · Ratios of the last two fiscal years on file
    Market cap $34 M (last known, Jan 5, 2024) · revenue $2 M (year to December 2024)
    100 of 100 (industry or sector 50 + size 30 + country 15 + figures on file 5)
    In the group
  • Abionyx Pharma SAABNX.PA · 🇫🇷 France
    Same industry: Biotechnology · Similar size: $45 M market cap against $36 M · Same country: France · Ratios of the last two fiscal years on file
    Market cap $45 M (last known, Jan 5, 2024) · revenue $5 M (year to December 2025)
    98 of 100 (industry or sector 50 + size 29 + country 15 + figures on file 5)
    In the group
  • Poxel S.A.POXEL.PA · 🇫🇷 France
    Same industry: Biotechnology · Similar size: $22 M market cap against $36 M · Same country: France · Ratios of the last two fiscal years on file
    Market cap $22 M (last known, Jan 5, 2024) · revenue $7 M (year to December 2024)
    97 of 100 (industry or sector 50 + size 27 + country 15 + figures on file 5)
    In the group
  • Genkyotex SAG061.F · 🇫🇷 France
    Same industry: Biotechnology · Similar size: $41 M market cap against $36 M · Same country: France
    Market cap $41 M (last known, Jan 1, 2021)
    94 of 100 (industry or sector 50 + size 29 + country 15)
    In the group
  • Fermentalg Societe Anonyme1F6.F · 🇫🇷 France
    Same industry: Biotechnology · Similar size: $30 M market cap against $36 M · Same country: France
    Market cap $30 M (last known, Jul 30, 2023)
    94 of 100 (industry or sector 50 + size 29 + country 15)
    In the group
  • Onxeo SAONXEO.CO · 🇫🇷 France
    Same industry: Biotechnology · Similar size: $46 M market cap against $36 M · Same country: France
    Market cap $46 M (last known, Jan 7, 2022)
    93 of 100 (industry or sector 50 + size 28 + country 15)
    In the group
  • OSE Immunotherapeutics SAOSE.PA · 🇫🇷 France
    Same industry: Biotechnology · Similar size: $101 M market cap against $36 M · Same country: France · Ratios of the last two fiscal years on file
    Market cap $101 M (last known, Jan 5, 2024) · revenue $3 M (year to December 2025)
    93 of 100 (industry or sector 50 + size 23 + country 15 + figures on file 5)
    In the group
  • Nicox SACOX.PA · 🇫🇷 France
    Same industry: Biotechnology · Similar size: $61 M market cap against $36 M · Same country: France
    Market cap $61 M (last known, Dec 25, 2022) · revenue $9 M (year to December 2021)
    92 of 100 (industry or sector 50 + size 27 + country 15)
    + Add
  • NFL Biosciences SAALNFL.PA · 🇫🇷 France
    Same industry: Biotechnology · Similar size: $19 M market cap against $36 M · Same country: France
    Market cap $19 M (last known, Jan 5, 2024)
    91 of 100 (industry or sector 50 + size 26 + country 15)
    + Add
  • Transgene SATNG.PA · 🇫🇷 France
    Same industry: Biotechnology · Similar size: $151 M market cap against $36 M · Same country: France · Ratios of the last two fiscal years on file
    Market cap $151 M (last known, Jan 5, 2024) · revenue $0 M (year to December 2025)
    91 of 100 (industry or sector 50 + size 21 + country 15 + figures on file 5)
    + Add
  • Oncodesign Societe AnonymeALONC.PA · 🇫🇷 France
    Same industry: Biotechnology · Similar size: $80 M market cap against $36 M · Same country: France
    Market cap $80 M (last known, Jan 7, 2022)
    90 of 100 (industry or sector 50 + size 25 + country 15)
    + Add
  • Adocia SAADOC.PA · 🇫🇷 France
    Same industry: Biotechnology · Similar size: $177 M market cap against $36 M · Same country: France · Ratios of the last two fiscal years on file
    Market cap $177 M (last known, Jan 5, 2024) · revenue $2 M (year to December 2025)
    90 of 100 (industry or sector 50 + size 20 + country 15 + figures on file 5)
    + Add

Any figure over the years, other peers or a saved group: open this group in the peer workspace.